In the dynamic realm of stock trading, a captivating segment can often catch the eye of countless investors: stocks trading under $1 on the OTC exchange. These intriguing securities, commonly known as penny stocks, attract those who enjoy ventures that are risky but rewarding.
Are you ready to set out on a journey that explores the thrilling world of these intriguing stocks? Let's set the stage with Epazz, Inc., an up and coming drone company that could hold immense promise
EPAZZ, INC. (OTC: EPAZ)
EPAZ is a provider of mission-critical business solutions, revolutionizing the way businesses operate with a diverse portfolio encompassing drone technology, blockchain mobile apps, and cloud-based business software.
In 2023, Epazz showcased its innovative technology through its subsidiary, ZenaDrone Inc. Specializing in intelligent unmanned aerial vehicle technology, ZenaDrone has seamlessly integrated machine learning software and AI to enhance its capabilities. While initially targeting the hemp farming sector, the ZenaDrone has expanded its reach, offering versatile solutions for industrial surveillance, inspection, and monitoring.
At the forefront of Epazz's technology stands the ZendaDrone 1000, an intelligent drone that has garnered significant attention in various demonstrations this year, notably from the US Military. The ZendaDrone 1000 has been recognized for its potential as a valuable tool in hazardous environments for package transport, as well as its capability in transporting critical medical supplies. Its advanced technology and adaptability make it an indispensable asset across various sectors.
In a recent move, Epazz announced the creation of Galaxy Batteries Inc., a subsidiary solely dedicated to housing the company's intellectual property in battery technology. Epazz has been actively engaged in the development of specialized batteries to power high-performance devices and aircraft, including the ZenaDrone 1000.
Dr. Shaun Passley, CEO of Epazz, said, "The journey of our drone project has paved the way for unforeseen opportunities that we couldn't have anticipated back in 2019. We are now actively evaluating how to monetize our diverse range of developed technologies and maximize the value they bring to our company."
With ongoing patent filings for their innovative battery technology, EPAZ envisions Galaxy Batteries emerging as an independent entity in the near future. To streamline and consolidate their battery technology initiatives, the company launched galaxybatteries.com, a dedicated website catering to the subsidiary's offerings.
Epazz's strategic venture into battery technology aligns with the surging demand for high-powered batteries for various devices. EPAZ is positioning itself favorably to capitalize on the expanding market. Investors should keep an eye on Epazz's battery technology subsidiary, which could hold potential and is could make an impact across multiple industries for EPAZ
Epazz's focus on advancing drone technology, combined with its explorations of cutting-edge battery innovations, shows its dedication to remaining at the forefront of technological advancements. With a unique approach in an ever-evolving landscape, EPAZ emerges as a compelling company that deserves close attention.
CLEAN VISION CORPORATION (OTC: CLNV)
CLNV is a company operating in the sustainable clean technology and green energy sectors. The company's focus is on acquiring and operating a portfolio of synergistic companies in these sectors.
In a company update from June 5, Clean Vision announced a significant development for its subsidiary, Clean-Seas West Virginia. Clean-Seas, Inc., a wholly-owned subsidiary of Clean Vision, is actively working towards providing efficient and cost-effective technology solutions to address the global plastic crisis.
The subsidiary focuses on plastic diversion and conversion, including securing plastic feedstock and off-take agreements. By deploying pyrolysis technology and forming strategic alliances, Clean-Seas aims to create economic opportunities and social benefits worldwide.
According to the company update, Clean-Seas West Virginia has signed a Memorandum of Agreement (MoA) with the West Virginia Department of Economic Development (WVDED). The MoA aims to leverage state incentives amounting to over $12 million to establish a manufacturing facility in West Virginia.
The facility will be dedicated to the conversion of plastic feedstock into precursors for recycled content plastics and clean fuels, including hydrogen. This initiative aligns with Clean Vision's commitment to delivering innovative solutions for a sustainable environment and supporting clean economic growth.
The project has received strong support from West Virginia Governor Jim Justice and WVDED Secretary Mitch Carmichael, who recognize the potential for job creation and industry development. The MoA includes $1.75 million in forgivable loans, with additional support provided through tax and employment incentives.
Once operational, the facility is expected to process 100 tons of plastic per day, starting in 2024, and gradually scale up to 500 tons per day. This project not only contributes to the clean energy sector but also addresses the global plastic crisis by removing harmful plastic from the environment.
Clean Vision's expansion into West Virginia and its commitment to clean energy demonstrate its dedication to sustainable practices and contributing to a cleaner, greener future.
ENZOLYTICS, INC. (OTC: ENZC)
ENZC is a drug development company focused on commercializing its proprietary proteins and monoclonal antibodies to treat infectious diseases. The company's primary compound, ITV-1 (Immune Therapeutic Vaccine-1), has shown promising results in treating HIV/AIDS and modulating the immune system.
In recent updates, Enzolytics provided details regarding the sale of its subsidiaries, Virogentics, Inc., and Biogenysis, Inc., to Sagaliam Acquisition Corp. The negotiations and regulatory filings are currently underway, with both parties working towards completing the transaction efficiently.
Furthermore, the Bulgarian Academy of Science for Korporativ Klinik Drug Research and Development conducted a comprehensive study that highlighted the efficacy and molecular composition of ITV-1. The preparation for phase 3 clinical trials, following the European Medicine Agency (EMA) guidelines, is in progress.
Furthermore, the final protocol for administering ITV-1 under the supervision of Neuro Pharma Ltd. in Rwanda is expected to be completed soon. The impact of the treatment on the HIV/AIDS virus will be reported after the 17-week cycle, with plans to begin the trial in late July or early August 2023.
Enzolytics continues to make significant strides in its projects and looks forward to ongoing success.
AMERICAN BATTERY TECHNOLOGY COMPANY (OTC: AMBL)
AMBL is a company focused on providing low-cost, environmentally friendly, and domestically sourced battery metals. With its three divisions focused on lithium-ion battery recycling, primary battery metal extraction technologies, and primary resource development, AMBL aims to meet the growing demand for battery metals. The company's ESG-principled platform emphasizes ethical and sustainable sourcing of critical materials, contributing to a closed-loop circular economy for battery metals.
Last month, AMBL announced financial results for its third fiscal quarter 2023, highlighting its continued and accelerated progress in bringing new, domestically manufactured battery metal products to market.
During this quarter, AMBL expanded its recycling business by securing a move-in-ready facility for lithium-ion battery recycling operations, with commissioning planned for summer 2023. AMBL also published a resource report for its Tonopah Flats Lithium Project, which is identified as one of the largest known lithium resources in the United States.
In addition, AMBL chose engineering firm Black & Veatch to build a commercial-scale lithium hydroxide refinery with the help of a US Department of Energy grant.
Key financial highlights include $12.6 million in cash as of March 31, 2023, and total operating costs that are 47% lower year over year.
In addition, AMBL is in final contract negotiations with the U.S. DOE for two recently awarded competitive grants to further develop its advanced recycling processes and the commercial refinery for lithium hydroxide production from claystone resources.
AMBL aims to continuously improve battery recycling and manufacturing processes to align with new technologies, conserve resources, reduce environmental impacts, and maintain economic viability. The company's participation in the DOE-funded initiative aims to enhance economic competitiveness and reintegrate more constituent components into the domestic battery manufacturing market.
For interested investors, AMBL's CEO, Ryan Melsert, will be sharing industry insights and perspectives on building a sustainable, domestic supply chain for lithium-ion battery materials at the TD Cowen Sustainability Week.
The virtual conference will feature a fireside chat with Melsert, hosted by David Deckelbaum, TD Cowen's equity research analyst and managing director of sustainability and energy transition. The fireside chat is scheduled for June 6, 2023, from 2:20-2:50 PM EST. The event will be live-streamed on AMBL's website and will be available for viewing for up to a year.
Disclaimers:CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) is owned by RazorPitch Inc. and has been retained by Epazz Inc. to assist in the production and distribution of content. 'CGR' is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport/RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR/RazorPitch is not a fiduciary by virtue of any persons use of or access to this content.
CONTACT: CapitalGainsReport
Mark McKelvie
Editor
Markrmckelvie@gmail.com
585-301-7700
.
EPAZZ, INC. 
